Fundz

Novanta Inc. acquires Riverpoint Medical for $1.2B

PUBLIC · NOVTJun 09, 2026

Acquiring Company

Novanta

Acquired Company

Riverpoint Medical

BedfordOtherManufacturingInformation TechnologyManufacturingBiotechnologyHealth CareMedical Device

Description

Novanta Inc. has announced its acquisition of Riverpoint Medical for $1.2 billion in cash. The transaction aims to strengthen Novanta's position in the medical sector by expanding its recurring revenue streams. Expected to close in the third quarter of 2026, the deal includes a future milestone payment of $250 million. This acquisition aligns with Novanta's strategy to enhance its portfolio with high-growth surgical consumables.

Who to call at Novanta, and when

When Novanta changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Novanta raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Novanta, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Novanta. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Novanta

Location

125 Middlesex Turnpike

Bedford, Massachusetts, United States

About

Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers (“OEMs”) a competitive advantage. We combine deep proprietary technology expertise and competencies in photonics, vision and precision motion with a proven ability to solve complex technical challenges. This enables Novanta to engineer core components and sub-systems that deliver extreme precision and performance, tailored to our customers’ demanding applications. The driving force behind our growth is the team of innovative professionals who share a commitment to innovation and customer success. Novanta’s common shares are quoted on Nasdaq under the ticker symbol “NOVT”. More information about Novanta is available on the Company’s website at www.novanta.com. For additional information, please contact Novanta Inc. Investor Relations at (781) 266-5137 or InvestorRelations@novanta.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Novanta makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Rebecca
Senior decision-maker at this company
••••••••@••••••••

See Rebecca's verified email →

John
Senior decision-maker at this company
••••••••@••••••••

See John's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Novanta's next move

Learn about Strategic plan

Frequently asked

Who acquired Riverpoint Medical?

Riverpoint Medical was acquired by Novanta, based in Bedford. The deal was reported on June 9, 2026. Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers (“OEMs”) a competitive advantage. Novanta is publicly traded (NOVT) and operates in Other.

When did Novanta acquire Riverpoint Medical?

Novanta's acquisition of Riverpoint Medical was reported on June 9, 2026. Novanta Inc. has announced its acquisition of Riverpoint Medical for $1.2 billion in cash. The transaction aims to strengthen Novanta's position in the medical sector by expanding its recurring revenue streams. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Riverpoint Medical do?

Riverpoint Medical is a leading developer, designer, and manufacturer of advanced surgical devices and related technologies. The company specializes in minimally invasive surgical consumables and provides its products to strategic OEM partners. It is privately held, operating in Manufacturing.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.